NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- MomMed, a trusted maternal and family wellness brand, today announced a strategic partnership with nasal care innovator Cleanote to launch a co-branded ...

NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- MomMed, a trusted maternal and family wellness brand, today announced a strategic partnership with nasal care innovator Cleanote to launch a co-branded ...

MONTREAL and CHARLOTTE, N.C., June 16, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced submission of its response to the U.S. Food and Drug Administration ...

The saline nasal spray is now officially available on mommed.com and Amazon, with nationwide U.S. shipping. About MomMed: We're not just a baby brand; we're your devoted companion in motherhood.

Etripamil is Milestone's lead investigational product. It is a novel calcium channel blocker nasal spray under clinical development for frequent and often highly symptomatic episodes of PSVT and ...

Milestone Pharmaceuticals Inc. (Nasdaq: MIST) is a biopharmaceutical company developing and commercializing innovative cardiovascular solutions to improve the lives of people living with complex ...

Object Details Location Currently not on view Credit Line Gift of ABC News "20/20" ID Number 1998.0252.043 accession number 1998.0252 catalog number 1998.0252.043 Object Name otc preparation Physical ...

GlobeNewswire Milestone Pharmaceuticals Submits Response to the FDA’s CRL for CARDAMYST (etripamil) Nasal Spray for PSVT Following Type A Meeting GlobeNewswire Updated June 16, 2025 8:07 AM ...

MONTREAL and CHARLOTTE, N.C., June 16, 2025 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today announced submission of its response to the U.S. Food and Drug Administration (FDA ...